Finance

Lists
214450:KOSDAQ
PharmaResearch Co Ltd
251 000,00 KRW
+1,41%
(+3 500,00) 1D
13-ноя., 15:30:26 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214450...
Open
247 500 KRW
High
253 500 KRW
Low
245 000 KRW
Mkt. cap
2,61 трлн
Avg. vol.
100,87 миң
Volume
73,79 миң
Dividend
1,47%
Quarterly dividend
925 KRW
Ex-dividend date
2024-ж., 27-дек.
P/E ratio
15,38
52-wk high
561 000 KRW
52-wk low
208 000 KRW
EPS
16 318 KRW
Shares outstanding
10,39 млн
No. of employees
550
Open
247 500 KRW
High
253 500 KRW
Low
245 000 KRW
Mkt. cap
2,61 трлн
Avg. vol.
100,87 миң
Volume
73,79 миң
Dividend
1,47%
Quarterly dividend
925 KRW
Ex-dividend date
2024-ж., 27-дек.
P/E ratio
15,38
52-wk high
561 000 KRW
52-wk low
208 000 KRW
EPS
16 318 KRW
Shares outstanding
10,39 млн
No. of employees
550
News stories
From web sources and news partners
About PharmaResearch Co Ltd
CEOJung Sangsoo
Employees550
Founded1993
Headquarters-
SectorHealth Care
Industry-
Websitepharmaresearch.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
135,43 млд
143,35 млд
146,10 млд
178,70 млд
Cost of goods sold
26,28 млд
33,92 млд
33,17 млд
41,16 млд
Cost of revenue
26,28 млд
33,92 млд
33,17 млд
41,16 млд
Research and development expenses
8,23 млд
11,80 млд
10,10 млд
13,44 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36,01 млд
42,78 млд
42,31 млд
54,78 млд
Operating expense
47,27 млд
59,58 млд
55,35 млд
71,01 млд
Total operating expenses
73,56 млд
93,50 млд
88,53 млд
112,17 млд
Operating income
61,87 млд
49,84 млд
57,57 млд
66,53 млд
Other non operating income
2,97 млд
-615,72 млн
-9,00 млд
8,57 млд
EBT including unusual items
64,83 млд
49,91 млд
68,02 млд
74,05 млд
EBT excluding unusual items
64,84 млд
50,89 млд
57,57 млд
75,11 млд
Income tax expense
13,97 млд
10,58 млд
19,27 млд
17,82 млд
Effective tax rate
21,56%
21,20%
28,33%
24,07%
Other operating expenses
290,06 млн
105,71 млн
540,02 млн
-212,36 млн
Net income
48,97 млд
32,57 млд
47,57 млд
56,57 млд
Net profit margin
36,16%
22,72%
32,56%
31,66%
Earnings per share
-
3,05 миң
4,24 миң
4,89 миң
Interest and investment income
-
5,81 млд
9,10 млд
-
Interest expense
-
-2,75 млд
-5,23 млд
-
Net interest expenses
-
3,06 млд
3,87 млд
-
Depreciation and amortization charges
1,46 млд
1,50 млд
1,55 млд
1,82 млд
EBITDA
65,89 млд
53,92 млд
61,77 млд
71,04 млд
Gain or loss from assets sale
-11,44 миң
-8,83 млн
-
-30,23 млн
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору